化学
纤维
蛋白质折叠
生物物理学
折叠(DSP实现)
球状蛋白
内在无序蛋白质
淀粉样蛋白(真菌学)
序列(生物学)
蛋白质聚集
淀粉样β
生物化学
淀粉样纤维
结晶学
生物
无机化学
病理
工程类
电气工程
医学
疾病
作者
Yiping Cao,Jozef Adamčík,Michael Diener,Janet R. Kumita,Raffaele Mezzenga
摘要
The propensity to self-assemble into amyloid fibrils with a shared cross-β architecture is a generic feature of proteins. Amyloid-related diseases affect millions of people worldwide, yet they are incurable and cannot be effectively prevented, largely due to the irreversible assembly and extraordinary stability of amyloid fibrils. Recent studies suggest that labile amyloids may be possible in certain proteins containing low-complexity domains often involved in the formation of subcellular membraneless organelles. Although the fundamental understanding of this reversible amyloid folding process is completely missing, the current view is that a given protein sequence will result in either irreversible, as in most of the cases, or reversible amyloid fibrils, as in few exceptions. Here we show that two common globular proteins, human lysozyme and its homologue from hen egg white, can self-assemble into both reversible and irreversible amyloid fibrils depending on the folding path followed by the protein. In both folding states, the amyloid nature of the fibrils is demonstrated at the molecular level by its cross-β structure, yet with substantial differences on the mesoscopic polymorphism and the labile nature of the amyloid state. Structural analysis shows that reversible and irreversible amyloid fibrils possess the same full-length protein sequence but different fibril core structures and β-sheet arrangements. These results illuminate a mechanistic link between the reversible and irreversible nature of amyloids and highlight the central role of protein folding states in regulating the lability and reversibility of amyloids.
科研通智能强力驱动
Strongly Powered by AbleSci AI